Thrombotic Disorders

Overview – Thrombotic Disorders

Thrombotic disorders refer to inappropriate clot formation within blood vessels due to excessive activation of the clotting cascade or impaired anticoagulant control. These clots—composed of platelets and fibrin—can obstruct blood flow, cause tissue ischaemia, or embolise to distant sites. They underlie many serious clinical conditions, including pulmonary embolism, stroke, and myocardial infarction. Understanding their mechanisms is essential for effective prevention and treatment.

Definition

  • Thrombosis = Inappropriate formation of fibrin and platelet clots
  • Leads to vascular obstruction → Ischaemia → Necrosis
  • Thromboembolism = A clot that dislodges and migrates to another site (e.g. DVT → PE)

Arterial Thrombosis

Mechanisms:

  1. Atherosclerotic Plaque Rupture
    • Rupture exposes subendothelial collagen & tissue factor
    • → Triggers platelet aggregation & coagulation → Thrombosis
  2. Thromboembolism

Risk Factors:

Common Presentations:

  • Stroke (CVA)
  • Myocardial infarction (MI)
  • Peripheral Arterial Disease (PAD)
Thrombotic Disorders - Arterial Thrombosis
Blausen Medical Communications, Inc., CC BY 3.0 <https://creativecommons.org/licenses/by/3.0>, via Wikimedia Commons

Venous Thrombosis

Sites:

  • Commonly in lower limbs (gravity-dependent venous pooling)
  • Deep & superficial veins
  • May lead to Pulmonary Embolism (PE)

Risk Factors:

Hereditary Hypercoagulable States:

  • Factor V Leiden mutation
  • Prothrombin G20210A variant
  • Protein C/S deficiency
  • Antithrombin III deficiency

Acquired Hypercoagulable States:

  • High-dose oestrogen therapy (↑Coagulation factors, ↓Antithrombin)
  • Surgery/trauma (tissue factor exposure + immobility)
  • Pregnancy/post-partum
  • Sepsis
  • Heparin-induced thrombocytopenia (HIT)
  • Venous stasis due to:

Treatment:

  • Anticoagulants (oral or parenteral)
  • Haemodynamic support
  • Endovascular clot retrieval (in severe cases)

Complications

  • Pulmonary embolism
    • 95% originate from leg/calf DVTs
    • Causes ischaemia or infarction of lung tissue
  • Post-thrombotic syndrome
  • Chronic venous insufficiency
Venous Thrombosis
thrombotic disorders - pulmonary embolus
1.Madsread, CC BY-SA 4.0 <https://creativecommons.org/licenses/by-sa/4.0>, via Wikimedia Commons
2.https://www.scientificanimations.com, CC BY-SA 4.0 <https://creativecommons.org/licenses/by-sa/4.0>, via Wikimedia Commons

Evaluation of Thrombotic Disorders

Indications for Thrombophilia Screening:

  • Family history
  • Unprovoked thrombosis at a young age
  • Recurrent DVT
  • Unusual sites (e.g. cerebral, hepatic, mesenteric veins)

Initial Workup:

  • FBC + ESR
    • Changes in platelets, haematocrit, fibrinogen
    • Evidence of haemolysis or inflammation
  • Prothrombin Time (PT)
    • Detects Factor VII deficiency
    • Reflects extrinsic pathway
  • Activated Partial Thromboplastin Time (aPTT)
    • Detects Factors VIII, IX, XI, XII deficiencies
    • Reflects intrinsic pathway
  • INR
    • Used to monitor warfarin therapy
    • Detects inadequate anticoagulation

If Both PT & aPTT Abnormal → Consider:

  • Liver disease
  • Vitamin K deficiency
  • Oral anticoagulant toxicity
Evaluation of Thrombotic Disorders

Summary – Thrombotic Disorders

Thrombotic disorders involve pathological clot formation within arteries or veins and can present as life-threatening events such as strokes, myocardial infarctions, or pulmonary emboli. Evaluation includes a detailed history, risk factor assessment, and lab testing (e.g. PT, aPTT, INR). Understanding underlying mechanisms is essential for guiding prevention and therapy. For broader haematological context, visit our Blood & Haematology Overview page.

Shopping Cart
Scroll to Top